News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Accentia Biopharmaceuticals CEO Takes on Second Job as Head of Biovest International, Inc.
March 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dr. Francis O’Donnell Jr. was appointed to serve as chief executive of Biovest International Inc. and will serve without any salary at the struggling biotech firm.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Foghorn cuts 40% of workforce
October 2, 2026
·
98 min read
·
BioSpace Editorial Staff
Duchenne muscular dystrophy
Sarepta could be ‘potential turnaround story’ with catalysts lined up into 2027
October 2, 2026
·
3 min read
·
Heather McKenzie
Deals
Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s Abogen
October 2, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Foghorn lays off 40% of staff after Lilly collaboration ends
October 1, 2026
·
2 min read
·
Angela Gabriel
